Direct oral anticoagulants vs warfarin in non-valvular atrial fibrillation. Meta-analysis, includes all published trials

Abstract Introduction Warfarin, despite its limitations, is still used as standard treatment in patients with Atrial Fibrillation, but it has been demonstrated that Direct Oral Anticoagulants (DOAC) offer many advantages over warfarin in the prevention of strokes. Purpose The goal was to determinate...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European heart journal 2021-10, Vol.42 (Supplement_1)
Hauptverfasser:	Arreaga-Perez, C, Evangelista-Barragan, D, Zarate-Zapata, A, Penaherrera, E, Zuniga-Bohorquez, J J, Garcia-Matamoros, F, Flores-Delgado, M, Barrera-Rivera, M, Bravo-Sanchez, P, Tejada-Franco, A, Gilbert-Orus, M D, Morejon-Barragan, P A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!